Stay updated on Clinical Trial: Reboxetine in Narcolepsy & Cataplexy
Sign up to get notified when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.

Latest updates to the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows a new revision version, indicating an administrative update to the page rather than changes to the study details or user-facing content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s revision tag was updated from v3.6.3 to v3.6.4, indicating a minor platform update.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing v3.6.2. This signals a minor update to the page, not altering study content or user-facing functionality.SummaryDifference0.1%

- Check57 days agoChange DetectedBottom-of-page revision label updated from v3.6.0 to v3.6.2, signaling a minor frontend update to the page. This change does not modify study content or user actions on the CONCERT study page.SummaryDifference0.1%

- Check64 days agoChange DetectedStudy locations were updated to include Stockbridge, GA and remove St. Petersburg, FL, and IPD data-sharing fields were added to indicate IPD sharing status.SummaryDifference0.8%

- Check71 days agoChange DetectedAdded recruitment status note No longer looking for participants and introduced user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) to aid visitors. Updated the Intervention/Treatment label formatting and included a Revision: v3.6.0 note, reflecting a content and documentation update.SummaryDifference0.4%

Stay in the know with updates to Clinical Trial: Reboxetine in Narcolepsy & Cataplexy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.